Weather

93°F1:30 PM

Health

1 read

US HIV/AIDS Funding Cliff Threatens Millions of Patients Worldwide

KVIA•Friday, July 10, 2026 at 4:01 AM•CNN Newsource

Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

AI Summary

A looming financial crisis is set to impact millions reliant on US-funded HIV/AIDS programs, particularly in Africa, as 120 funding awards from the CDC are set to expire by October 1. These programs, part of the President’s Emergency Plan for AIDS Relief (PEPFAR), serve over 8.7 million patients globally and provide essential services such as community testing and clinical care. The restructuring of PEPFAR by the State Department raises concerns about the initiative's future effectiveness, as it shifts control away from health experts at the CDC. Critics warn that this could lead to significant disruptions in healthcare services, especially in countries like Mozambique, Tanzania, and South Africa, which will be disproportionately affected.

Key Details: • 120 CDC funding awards expire on October 1, 2023, with no replacements. • PEPFAR has saved over 26 million lives since its inception in 2003. • Countries like Mozambique, Tanzania, and South Africa will face severe impacts. • State Department's new strategy involves a shift to one-on-one funding agreements with countries.

healthcare funding hiv global-health aids

People & Organizations

South AfricaUS State DepartmentAfricaTanzaniaPresident’s Emergency Plan for AIDS ReliefMozambiqueUS Centers for Disease Control

Related Articles

Understanding Medication Formularies: A Key to Cost-Effective Healthcare in El Paso

Navigating health insurance plans can be challenging, especially when it comes to understanding medication formularies. These formularies are lists of covered medications that can significantly impact your out-of-pocket costs. They are organized into tiers, with lower tiers typically offering lower copays. It's essential for El Paso residents to review their health plan's formulary to ensure their necessary prescriptions are covered and to avoid unexpected expenses. If a medication isn't listed, patients may need to request an exception or pay out of pocket. Knowing how to utilize this tool can lead to better healthcare decisions and savings.

Sardinia's Centenarians: Men and Women Live Equally Long in Unique Villages

In Sardinia's Blue Zone, the traditional gender longevity gap nearly disappears, with men reaching 100 years at almost the same rate as women. This phenomenon is particularly evident in the village of Villagrande Strisaili, where men slightly outnumber women among centenarians, a rarity globally. Research indicates that the gut microbiome plays a crucial role in this longevity, particularly a microbe called Akkermansia muciniphila, which is significantly more abundant in Sardinian centenarians compared to younger adults. This discovery highlights the importance of gut health and diet in aging, making it a topic of interest for further studies in longevity.

Majority of Americans Support FDA Accessibility for Popular Peptides

A recent survey by Hone Health reveals that 83% of U.S. adults familiar with peptides advocate for the FDA to allow licensed compounding pharmacies to produce seven specific peptides with a physician's prescription. The Pharmacy Compounding Advisory Committee (PCAC) will meet on July 23-24, 2026, to discuss adding these peptides to the 503A Bulks List, which would enable safer access for consumers currently relying on unregulated sources. Dr. Abid Husain emphasizes that regulated access could mitigate risks associated with gray-market peptides, which often contain harmful impurities. The decision from the FDA is expected by late 2026, with 39% of potential users indicating that reclassification would encourage them to try peptides.

El Paso's Unique Weight-Loss Program Highlights GLP-1s for Effective Management

The Hospitals of Providence Weight-Loss Program has received accreditation as the sole designated weight-loss surgery and medicine program in the El Paso region. Dr. Benjamin Clapp discussed the increasing use of GLP-1 medications for weight management during an interview, emphasizing their effectiveness alongside potential risks and side effects. This development is significant for local residents seeking weight-loss solutions, as it positions the program as a leading resource in the area. Patients considering GLP-1 treatments should be aware of both the benefits and drawbacks associated with these medications.